Bausch Health (LTS:0QYW) Interest Expense: CHF-1,277 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QYW Bausch Health Companies Inc LTS:0QYW
65 GF Score
Price CHF122.94
GF Value CHF157.98
! 3 Warning Signs
View Full Analysis

What is Bausch Health Interest Expense?

Bausch Health LTS:0QYW 65 Interest Expense is CHF-1,277 Mil as of Jun. 2026. GuruFocus rates LTS:0QYW with a GF Score™ of 65/100 and a GF Value™ of CHF157.98. The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Bausch Health's interest expense for the three months ended in Jun. 2026 was CHF -317 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2026 was CHF-1,277 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Bausch Health's Operating Income for the three months ended in Jun. 2026 was CHF 619 Mil. Bausch Health's Interest Expense for the three months ended in Jun. 2026 was CHF -317 Mil. Bausch Health's Interest Coverage for the quarter that ended in Jun. 2026 was 1.96. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bausch Health  (LTS:0QYW) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Bausch Health's Interest Expense for the three months ended in Jun. 2026 was CHF-317 Mil. Its Operating Income for the three months ended in Jun. 2026 was CHF619 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2026 was CHF15,904 Mil.

Bausch Health's Interest Coverage for the quarter that ended in Jun. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Jun. 2026 )/Interest Expense (Q: Jun. 2026 )
=-1*619.457/-316.523
=1.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Warning Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Bausch Health Companies Inc interest coverage is 1.7, which is low.

Bausch Health Interest Expense Historical Data

* Premium members only.

The historical data trend for Bausch Health's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health Interest Expense Chart

Bausch Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,313.35 -1,363.86 -1,148.45 -1,237.54 -1,278.23

Bausch Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -378.14 -327.99 -316.37 -316.50 -316.52
LTS:0QYW
65GF Score
Bausch Health Companies Inc LTS:0QYW
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bausch Health Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-1,277 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of CHF-1,277 Mil mean?
Bausch Health (LTS:0QYW) has a Interest Expense of CHF-1,277 Mil as of Jun. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bausch Health and its competitors.
Is Bausch Health's Interest Expense too high?
Bausch Health's current Interest Expense is CHF-1,277 Mil. Overall, Bausch Health has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does Bausch Health's Interest Expense compare to ZTS?
Bausch Health's Interest Expense of CHF-1,277 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Bausch Health and its competitors. Bausch Health's current Interest Expense is CHF-1,277 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bausch Health stock overvalued right now?
Bausch Health (LTS:0QYW) has a current Interest Expense of CHF-1,277 Mil. The stock's GF Value™ is CHF157.98, compared to a current price of CHF122.94 — trading 22.2% below its estimated fair value. The current Interest Expense is CHF-1,277 Mil. Bausch Health's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Bausch Health (LTS:0QYW), the current Interest Expense is CHF-1,277 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bausch Health (LTS:0QYW) Overvalued in 2026?

Based on GuruFocus' analysis, Bausch Health stock appears to be undervalued. The current stock price of CHF122.94 is trading 22.2% below its estimated GF Value™ of CHF157.98.

Key valuation signals for LTS:0QYW:

  • Interest Expense: CHF-1,277 Mil
  • GF Value™: CHF157.98 vs. price of CHF122.94 (22.2% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the LTS:0QYW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bausch Health Business Description

Address 2150 St Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
65GF Score

Get the complete analysis for LTS:0QYW

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF122.94
Price
CHF157.98
GF Value